This inventor holds 1 USPTO granted patent. Top assignee: Unichem Laboratories Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Nsk Senthil Kumar: Innovator in Pharmaceutical Technology
Introduction
Nsk Senthil Kumar is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and convenience of medications for patients.
Latest Patents
Nsk Senthil Kumar holds a patent for Tofacitinib orally disintegrating tablets. This invention relates to Orally Disintegrating Tablets (ODT) of Tofacitinib and its pharmaceutically acceptable salts, along with the process to produce these tablets. The invention further includes ODTs comprising Tofacitinib and its pharmaceutically acceptable salts, at least one sweetening agent, at least one disintegrant, and optionally other excipients. The weight of the Orally Disintegrating tablets is 200 mg or less. Additionally, the invention encompasses Orally Disintegrating Tablets of Tofacitinib Citrate. Nsk Senthil Kumar has 1 patent to his name.
Career Highlights
Nsk Senthil Kumar is currently associated with Unichem Laboratories Limited, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulation and delivery, making medications more accessible and effective for patients.
Collaborations
Some of his coworkers include Milind Vinayak Sathe and Saurabh Gupta, who collaborate with him in various projects at Unichem Laboratories Limited.
Conclusion
Nsk Senthil Kumar is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to drug delivery systems. His patent for Tofacitinib orally disintegrating tablets exemplifies his commitment to improving patient care through effective medication solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile